DR REDDYS LABORATORIES LTD

Annual Trend FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026
Cash flows from operating activities:
Net Income $45.1b $55.7b $56.5b $42.9b
Net Income From Continuing Operations $45.1b $55.7b $57.2b $42.5b
Depreciation and amortization $11.3b $11.7b $176.0m $165.0m $175.0m $156.0m $154.0m $178.0m $200.0m $220.0m
Amortization Cash Flow $5.3b $6.6b $8.0b
Amortization Of Intangibles $5.3b $6.6b $8.0b
Depreciation Amortization Depletion $12.6b $14.8b $17.1b $20.6b
Deferred Income Tax $15.3b $16.2b $19.5b $12.4b
Deferred Tax $15.3b $16.2b $19.5b $12.4b
Adjustments For Share-Based Payments $7.0m $6.0m $7.0m $8.0m $8.0m $5.0m $5.0m $5.0m
Impairment of non-current assets, net $445.0m $53.0m $3.0m $222.0m $117.0m $100.0m $9.0m $1.0m $20.0m $38.0m
Equity settled share-based payment expense $350.0m $454.0m $6.0m $7.0m $8.0m $8.0m $5.0m $5.0m $5.0m $3.0m
Asset Impairment Charge $5.6b $3.6b $6.9b $11.0b
Adjustments For Income Tax Expense $70.0m $53.0m ($19.0m) $125.0m $115.0m $186.0m $194.0m $229.0m
Proceeds From Sales Of Investments Other Than Investments Accounted For Using Equity Method $984.0m $1.1b $1.5b $1.1b $1.0b $1.4b $1.6b $3.3b
Interest (income)/expense, net $76.0m $248.0m $2.0m $1.0m $2.0m $0 $3.0m ($7.0m) $2.0m $0
Earnings (Loss)es From Equity Investments ($370.0m) ($147.0m) ($217.0m) ($134.0m)
Additional Financial Items
Adjustments For Unrealised Foreign Exchange Losses Gains ($5.0m) ($23.0m) ($29.0m) $25.0m ($10.0m) ($11.0m) ($6.0m) $2.0m
Goodwill $61.0m $56.0m $53.0m $62.0m $58.0m $52.0m $51.0m $138.0m
Payments To Acquire Or Redeem Entitys Shares $0 $0 $0
Proceeds From Borrowings Classified As Financing Activities $66.6b $42.9b $29.8b $48.3b $51.5b $49.2b $19.4b $80.6b
Proceeds From Issuing Shares $0 $0
Purchase Of Intangible Assets Classified As Investing Activities $27.0m $8.0m $17.0m $39.0m $58.0m $92.0m $132.0m $81.0m
Repayments Of Borrowings Classified As Financing Activities $65.7b $58.1b $48.5b $41.4b $48.0b $68.6b $13.9b $56.2b
Profit for the year $12.0b $9.8b $272.0m $259.0m $17.2b $311.0m $548.0m $668.0m $671.0m $452.0m
Tax expense, net $2.6b $4.5b $53.0m ($19.0m) $125.0m $115.0m $186.0m $194.0m $229.0m $132.0m
Fair value changes and profit on sale of financial instruments measured at FVTPL, net ($929.0m) ($557.0m) ($4.0m) ($11.0m) ($38.0m) ($42.0m) ($25.0m)
Allowance for credit losses (on trade receivables and other advances) $155.0m $420.0m $3.0m $3.0m $1.0m $2.0m $3.0m $2.0m $8.0m
(Profit)/ Loss on sale/disposal of assets, net $68.0m $42.0m ($15.0m) $3.0m ($11.0m) ($18.0m) ($27.0m)
Share of profit of equity accounted investees ($349.0m) ($344.0m) ($6.0m) ($7.0m) ($7.0m) ($9.0m) ($5.0m) ($2.0m) ($3.0m) ($1.0m)
Unrealized exchange (gain)/loss, net $609.0m ($296.0m) ($23.0m) ($29.0m) $25.0m ($10.0m) ($11.0m) ($6.0m) $2.0m ($6.0m)
Inventories write-down $3.1b $2.9b $4.0b $2.5b $4.6b $59.0m $43.0m $61.0m $80.0m
Trade and other receivables $3.0b ($2.1b) $26.0m ($165.0m) $28.0m ($224.0m) ($70.0m) ($97.0m) ($120.0m) ($72.0m)
Inventories ($6.3b) ($3.2b) ($123.0m) ($20.0m) ($135.0m) ($70.0m) ($32.0m) ($221.0m) ($149.0m) ($92.0m)
Trade and other payables $1.9b $2.5b $6.0m $21.0m $39.0m $58.0m $0 $42.0m $4.0m $30.0m
Other assets and other liabilities, net ($3.9b) ($6.1b) $8.0m $64.0m ($45.0m) $53.0m $6.0m $34.0m ($85.0m) $11.0m
Cash generated from operations $27.3b $20.8b $485.0m $490.0m $566.0m $468.0m $847.0m $786.0m $779.0m $751.0m
Purchase of other intangible assets ($28.7b) ($1.8b) ($8.0m) ($17.0m) ($39.0m) ($58.0m) ($92.0m) ($132.0m) ($81.0m) ($161.0m)
Proceeds from sale of other intangible assets $0 $885.0m $3.0m $0 $39.0m $0 $1.0m $9.0m $15.0m
Payment for acquisition of businesses ($17.0m) $0 $0 ($15.5b) ($4.0m) $0 $0 ($622.0m) ($34.0m)
Investment in associates ($86.0m) $0 $0 $0 $0 ($1.0m) ($4.0m) ($1.0m)
Proceeds from issuance of equity shares (including treasury shares) $1.0m $1.0m $0 $0 $269.0m $4.0m $2.0m $10.0m $2.0m $4.0m
Purchase of treasury shares $0 $0 ($8.0m) ($6.0m) ($16.0m) $0 $0 $0 ($16.0m) $0
Proceeds from/(repayment of) short-term borrowings, net $21.5b ($18.0b) ($219.0m) $56.0m $93.0m $3.5b ($236.0m) $66.0m $287.0m $215.0m
Proceeds from long-term borrowings (Refer to Note 16 for details) $52.0m $0 $0 $46.0m $0 $0
Repayment of long-term borrowings (Refer to Note 16 for details) ($22.9b) ($51.0m) $0 $0 ($46.0m) $0 $0
Proceeds from issuance of equity shares in subsidiary comprising NCI (Refer to Note 35.A for details) $0 $0 $83.0m $0
Payment of principal portion of lease liabilities (Refer to Note 16 for details) ($157.0m) ($56.0m) ($6.0m) ($754.0m) ($10.0m) ($12.0m) ($14.0m) ($15.0m) ($13.0m)
Beginning Cash Position $14.9b $5.8b $7.1b $14.6b
Cash Flow From Continuing Financing Activities ($26.9b) ($3.8b) $18.9b $8.3b
Cash Flow From Continuing Investing Activities ($41.4b) ($40.3b) ($58.1b) ($65.5b)
Change In Account Payable $340.0m $2.8b
Change In Inventory ($2.7b) ($18.4b) ($12.8b) ($8.6b)
Change In Other Working Capital $528.0m $2.9b ($7.3b) $897.0m
Change In Payable $23.0m $3.5b $340.0m $2.8b
Change In Payables And Accrued Expense $23.0m $3.5b $340.0m $2.8b
Change In Receivables ($5.8b) ($8.1b) ($10.3b) ($6.7b)
Change In Working Capital ($7.9b) ($20.2b) ($30.0b) ($11.6b)
Changes In Account Receivables ($10.3b) ($6.7b)
Changes In Cash ($9.4b) $1.4b $7.3b ($468.0m)
End Cash Position $5.8b $7.1b $14.6b $15.4b
Financing Cash Flow ($26.9b) ($3.8b) $18.9b $8.3b
Free Cash Flow $40.0b $18.0b $12.0b $18.3b
Interest Received CFI $777.0m $1.3b $3.4b $1.5b
Investing Cash Flow ($41.4b) ($40.3b) ($58.1b) ($65.5b)
Issuance Of Capital Stock $368.0m $805.0m $193.0m $397.0m
Net Business Purchase And Sale $0 ($12.0m) ($53.4b) ($3.2b)
Net Foreign Currency Exchange Gain Loss ($939.0m) ($534.0m) $211.0m ($529.0m)
Net Intangibles Purchase And Sale ($7.5b) ($11.0b) ($6.2b) ($13.7b)
Net PPE Purchase And Sale ($11.2b) ($15.3b) ($27.0b) ($23.0b)
Operating Gains Losses ($1.1b) ($1.6b) ($1.5b) ($3.2b)
Other Non Cash Items $248.0m ($567.0m) $152.0m $12.0m
Provisionand Write Offof Assets $205.0m $275.0m $161.0m $690.0m
Purchase Of Business $0 ($12.0m) ($53.4b) ($3.2b)
Purchase Of Intangibles ($7.5b) ($11.0b) ($6.9b) ($15.1b)
Purchase Of PPE ($11.3b) ($16.4b) ($27.5b) ($23.3b)
Repurchase Of Capital Stock $0 $0 ($1.4b) $0
Sale Of Intangibles $0 $21.0m $732.0m $1.4b
Sale Of PPE $82.0m $1.1b $512.0m $309.0m
Stock Based Compensation $397.0m $407.0m $424.0m $326.0m
Unrealized Gain Loss On Investment Securities ($876.0m) ($3.1b) ($3.6b) ($2.4b)
Profit or Loss $151.0m $272.0m $259.0m $236.0m $311.0m $548.0m $668.0m $671.0m
Proceeds From Sales Of Property Plant And Equipment Classified As Investing Activities $44.0m $2.0m $18.0m $2.0m $1.0m $5.0m $1.0m $13.0m $6.0m $3.0m
Purchase of property, plant and equipment ($12.3b) ($9.3b) ($101.0m) ($64.0m) ($133.0m) ($193.0m) ($138.0m) ($197.0m) ($322.0m) ($249.0m)
Capital Expenditure Reported ($19.0b) ($18.9b)
Purchase of other investments (including bank deposits) ($49.7b) ($68.4b) ($1.1b) ($1.5b) ($1.0b) ($1.2b) ($1.7b) ($1.7b) ($3.0b) ($498.0m)
Net Investment Purchase And Sale ($23.4b) ($15.7b) $25.1b ($27.1b)
Purchase Of Investment ($136.2b) ($41.6b) ($28.5b) ($46.7b)
Proceeds from sale of other investments (including bank deposits) $71.6b $64.0b $1.1b $1.5b $1.1b $1.0b $1.4b $1.6b $3.3b $209.0m
Sale Of Investment $112.8b $25.9b $53.6b $19.6b
Net cash used in investing activities ($18.5b) ($14.9b) ($112.0m) ($65.0m) ($310.0m) ($348.0m) ($503.0m) ($483.0m) ($682.0m) ($700.0m)
Cash flows from financing activities:
Issuance Of Debt $0 $3.8b $0 $0
Long Term Debt Issuance $0 $3.8b $0 $0
Net Issuance Payments Of Debt ($20.4b) $4.3b $23.2b $19.0b
Net Long Term Debt Issuance ($1.0b) ($1.1b) ($1.3b) ($1.3b)
Net Short Term Debt Issuance ($19.4b) $5.5b $24.5b $20.3b
Short Term Debt Issuance $3.5b $24.5b $20.3b
Long Term Debt Payments ($1.0b) ($4.9b) ($1.3b) ($1.3b)
Repayment Of Debt ($1.0b) ($4.9b) ($1.3b) ($1.3b)
Common Stock Issuance $368.0m $805.0m $193.0m $397.0m
Net Common Stock Issuance $368.0m $805.0m ($1.2b) $397.0m
Common Stock Payments $0 $0 ($1.4b) $0
Dividends paid $4k $4k $4k $4k $4k $5k $7k $7k
Dividends Paid Classified As Financing Activities $61 $58 $52 $57 $55 $61 $80 $78
Dividends Paid Ordinary Shares Per Share $20.00 $20.00
Dividend income $0 $0 $0 $0 $0 $0 $0 $0 $0
Dividends received from equity accounted investees $0 $0 $5.0m $0 $0 $5.0m $0 $0
Interest and dividend received $628.0m $412.0m $11.0m $8.0m $17.0m $12.0m $9.0m $16.0m $38.0m $16.0m
Dividend paid ($3.4b) ($4.0b) ($58.0m) ($52.0m) ($57.0m) ($55.0m) ($61.0m) ($80.0m) ($78.0m) ($71.0m)
Cash Dividends Paid ($5.0b) ($6.6b) ($6.7b) ($6.7b)
Dividends Received CFI $0 $445.0m $0 $0
Net cash from/(used) in financing activities ($3.7b) ($4.4b) ($308.0m) ($334.0m) ($4.0m) ($32.0m) ($327.0m) ($45.0m) $222.0m $88.0m
Effect of exchange rate changes on cash and cash equivalents ($492.0m) $57.0m $1.0m $0 $113.0m $10.0m $3.0m ($1.0m) $1.0m $13.0m
Effect Of Exchange Rate Changes $286.0m ($59.0m) $224.0m $1.2b
Net increase/(decrease) in cash and cash equivalents ($650.0m) ($1.3b) ($5.0m) ($3.0m) $174.0m ($9.0m) ($114.0m) $17.0m $85.0m ($5.0m)
Cash and cash equivalents at the beginning of the year $3.8b $2.5b $2.2b $2.0b $14.8b $196.0m $70.0m $85.0m $171.0m $164.0m
Change In Cash Supplemental As Reported ($9.4b) $1.4b $7.3b ($468.0m)
Interest Paid Classified As Financing Activities ($925.0m) $20.0m $23.0m $21.0m $18.0m $18.0m $23.0m $27.0m $41.0m ($47.0m)
Income tax paid, net ($5.8b) ($2.8b) ($70.0m) ($94.0m) ($78.0m) ($98.0m) ($130.0m) ($241.0m) ($234.0m) ($144.0m)

Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.